Analysis of FDA approvals of targeted anticancer combination regimens

Am J Health Syst Pharm. 2017 Dec 1;74(23):1938-1942. doi: 10.2146/ajhp170029.
No abstract available

Keywords: antineoplastic agents; combined modality therapy; drug approval; hematologic neoplasms; pharmaceutical preparations.

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols*
  • Drug Approval*
  • Drug Delivery Systems
  • Humans
  • Neoplasms / drug therapy
  • United States
  • United States Food and Drug Administration*